TWINLAB CONSOLIDATED HOLDINGS, INC.

Overview

• IndustryMedicinal Chemicals & Botanical Products¹
• HeadquartersBoca Raton, Florida¹
• Incorporated inNV²
• Business address4800 T-Rex Avenue, Suite 305, Boca Raton, Fl 33431²
• Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Twinlab Consolidated Holdings, Inc. (references to “we”, “our”, “us”, the “company”, or “TCH”) was incorporated on October 24, 2013 under the laws of the State of Nevada.³ From its latest annual report

Corporate structure

TWINLAB CONSOLIDATED HOLDINGS, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What TWINLAB CONSOLIDATED HOLDINGS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Intangibles and goodwill

Inventory

Properties, in its own words

We occupied approximately 1,500 rentable square feet on the 2nd floor of an office building in Boca Raton, Florida under a lease that was scheduled to expire in October 2025. We leased approximately 13,000 rentable square feet on the 3rd floor of office space within the same building in Boca Raton, Florida under a lease agreement that expires February 2026. These leases were forfeited to the landlord on March 26, 2025.

We had possession of approximately 30,600 rentable square feet of office space, evenly split between the 5th and 6th floor of an office building in St. Petersburg, Florida under a lease that is scheduled to expire on April 30, 2027. On December 1, 2019, we entered into a sublease for the 6th floor space that is scheduled to expire on April 2027, and on December 1, 2016, we entered into a sublease for the 5th floor space which expired on June 30, 2022. On November 14, 2025, we received a notice of default from counsel regarding this lease for overdue rent payments and the sublease was surrendered to the landlord. On December 10, 2025, the landlord filed a compliant for damages in the Circuit Court for the Sixth Judicial Circuit in and for Pinellas and Pasco Counties, Florida, Civil Division. See Note 13 in the Notes to the Consolidated Financial Statements included in this report for a discussion of the notice of default and the lawsuit.

Item 2 of the 10-K filed Mar 3, 2026.³

Leadership

Who has led TWINLAB CONSOLIDATED HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.

• Chief executive officerNaomi Whittel Mar 28, 2016 to Oct 13, 2016¹⁴
• Chief executive officerThomas A. Tolworthy Sep 24, 2014 to Oct 23, 2015¹⁵
• PresidentThomas A. Tolworthy Sep 24, 2014 to Oct 23, 2015¹⁵
• Chief financial officerKyle Casey Oct 18, 2019 to Oct 18, 2019¹⁶
• Chief financial officerCarla Goffstein Aug 24, 2018 to Aug 24, 2018¹⁷
• Chief financial officerAlan S. Gever Mar 24, 2017 to Mar 24, 2017¹⁸
• Chief financial officerMark R. Jaggi Sep 24, 2014 to Sep 24, 2014¹⁹
• Chief operating officerAlan S. Gever Mar 24, 2017 to Mar 24, 2017¹⁸

Former names

• MIRROR ME, INC.Dec 27, 2013 to Aug 8, 2014²

Timeline

1. Sep 2, 20268-K Entered a material agreement; Bankruptcy or receivership; Completed an acquisition or sale³²
2. Nov 28, 20238-K Executive or director change³³
3. Mar 16, 20238-K Executive or director change³⁴
4. Feb 14, 20238-K Executive or director change³⁵
5. Feb 14, 20238-K Executive or director change³⁶
6. Dec 12, 20228-K Executive or director change³⁷
7. Sep 26, 20228-K Executive or director change³⁸
8. Mar 17, 20228-K Other events³⁹
9. Oct 7, 20218-K Executive or director change⁴⁰
10. Mar 28, 2016New chief executive Naomi Whittel becomes CEO¹⁴
11. Sep 24, 2014New chief executive Thomas A. Tolworthy becomes CEO¹⁵

Filings

28 filings to the SEC since October 2021: 4 annual reports, 10 quarterly reports, 9 major events, 1 insider forms, 1 large holders, 3 other. The latest 20:

1. Sep 2, 20268-K EDGAR
2. Mar 3, 202610-K EDGAR
3. Oct 16, 202510-Q EDGAR
4. Apr 24, 2025SCHEDULE 13D/A EDGAR
5. Apr 23, 20254 PRIMARY DOCUMENT EDGAR
6. Aug 1, 202410-Q EDGAR
7. May 9, 202410-Q EDGAR
8. Mar 19, 202410-K EDGAR
9. Nov 28, 20238-K EDGAR
10. Nov 14, 202310-Q EDGAR
11. Aug 14, 202310-Q EDGAR
12. Apr 24, 202310-Q EDGAR
13. Mar 31, 202310-K EDGAR
14. Mar 16, 20238-K EDGAR
15. Feb 14, 20238-K EDGAR
16. Feb 14, 20238-K EDGAR
17. Dec 12, 20228-K EDGAR
18. Oct 31, 202210-Q EDGAR
19. Sep 26, 20228-K EDGAR
20. Aug 24, 2022UPLOAD EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 0 buys and 1 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Akretive Holdings LLCSCHEDULE 13D/A, 1 filing Apr 24, 2025⁴¹

SEC filer profile

How TWINLAB CONSOLIDATED HOLDINGS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARTWINLAB CONSOLIDATED HOLDINGS, INC.¹
• CIK0001590695
• Employer ID (EIN)46-3951742³
• Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company³
• Incorporated inNevada³
• Fiscal year endsDecember 31¹
• Industry code (SIC)2833 Medicinal Chemicals & Botanical Products¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business address4800 T-Rex Avenue, Suite 305, Boca Raton, FL 33431¹
• Phone561-443-5001¹
• Shares outstanding259,092,833 shares as of Mar 2, 2026³
• Public float$1.0M as of Jun 30, 2024³
• AuditorTanner LLP, Lehi, Utah PCAOB ID 270; no auditor attestation of internal control over financial reporting³
• On EDGAR sinceDec 27, 2013¹
• Filings355 in all: 8-K (101), 4 (87), 10-Q (34), 3 (25), 4/A (20), SC 13D/A (20), 10-K (11), D (7)¹
  All 31 form types

  NT 10-Q (7), UPLOAD (6), NT 10-K (5), SC 13D (4), CORRESP (3), DEF 14A (3), S-1/A (3), 3/A (2), 8-K/A (2), CT ORDER (2), 10-K/A (1), 10-Q/A (1), 424B2 (1), 8-A12G (1), DEF 14C (1), DEFA14A (1), EFFECT (1), PRE 14C (1), S-1 (1), S-8 (1), S-8 POS (1), SC 14F1 (1), SCHEDULE 13D/A (1)

• Latest filingsAnnual report (10-K) Mar 3, 2026
  Quarterly report (10-Q) Oct 16, 2025
  Proxy statement (DEF 14A) Sep 28, 2018
  Latest 8-K (8-K) Sep 2, 2026

Risk factors and legal proceedings

The risks TWINLAB CONSOLIDATED HOLDINGS, INC. names in Item 1A of its 10-K filed Mar 3, 2026: 32 risks under these headings, as written.³

• Bankruptcy Risks
• We may file for bankruptcy protection, or an involuntary petition for bankruptcy may be filed against us.
• If we file for bankruptcy protction, our business and operations will be subject to certain risks.
• Market and Channel Risks
• Geopolitical issues, conflicts and other global events could adversely affect our results of operations and financial condition.
• Adverse economic conditions related to the COVID-19 pandemic or future pandemic may harm our business.
• Our success is linked to the size and growth rate of the vitamin, mineral and supplement market and an adverse change in the size or growth rate of that market could have a material adverse effect on us.
• Because a substantial portion of our sales are to or through health food stores, we are dependent to a large degree upon the success of this channel as well as the success of specific retailers in the channel.
• We are highly dependent upon consumers' perception of the safety and quality of our products as well as similar products distributed by other companies in our industry, and adverse publicity and negative public perception regarding particular ingredients or products or our industry in general could limit our ability to increase revenue and grow our business.
• We face intense competition from competitors that are larger, more established and that possess greater resources than we do, and if we are unable to compete effectively, we may be unable to maintain sufficient market share to sustain profitability.
• We may be affected adversely by future increases to utility and fuel costs.
• Business Strategy and Operational Risks

Legal proceedings

We are, from time to time, a party to legal proceedings that arise in the ordinary course of business.

On November 14, 2025, counsel to First Central Tower Limited Partnership ("Landlord") remitted a notice of Default, Demand to Cure and for Acceleration of Rent to us seeing $979,885 in unpaid rent. We did not respond to this notice.

On December 10, 2025, the Landlord filed a complain for damages in the Circuit Court for the Sixth Judicial Circuit in and for Pinellas and Pasco Counties, Florida, Civil Division, for past due rent. The landlord alleges that we defaulted on the lease by failing to pay rent on the date rent was due. The landlord is seeing to recover damages from us in the amount of $963,363, comprised of past due rent and late fees through December 2025, totaling $1,394,221, less our security deposit in the amount of $1,000,000, plus accelerated rent due for the remainder of the lease term reduced to the net present value in the amount of $360,713 plus costs associated with reletting the premises in the amount of $208,428. As of the date of filing this Form 10-K, we have not responded to this complain. It is possible that our failure to respond to the complain will result in a default judgment against us or alternatively that any response to the complaint or future actions on our part to defend against this litigation will be unsuccessful and result in an adverse judgment against us. Such a default or adverse judgment could result in the imposition of material damages and other costs and could have a material adverse effect on us. See Note 13 in the Notes to Consolidated Financial Statements included in this report for additional information.

The opening of Item 3, Legal Proceedings.³